Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine effects on top-down and bottom-up neural processing in healthy adults
NL-OMON40584Active, not recruiting
- Sponsor
- Leiden University
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of atomoxetine (2 arms), sponsored by Leiden University. Primary endpoints: Resting-state fMRI network functional connectivity, Behavioral decision-making variables in random dot motion task and 5 more. Started Mar 2014; status: active, not recruiting.
02
Drugs
atomoxetine
Beyond the preview
Go deeper on NL-OMON40584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40584.